Oral Drug Product Administration via Enteral Feeding Tubes: In Vitro Testing.

Area of Science:

• Pharmaceutical Sciences
• Clinical Pharmacy Practice
• Drug Delivery Systems

Background:

• Enteral feeding tubes (EFTs) are crucial for patients unable to swallow oral medications.
• Off-label use of oral drug products via EFTs presents significant risks to patients and caregivers.
• Current practices lack standardized, data-supported instructions for safe EFT medication administration.

Purpose of the Study:

• To present an industry perspective on necessary testing for oral drug products administered via EFT.
• To propose a risk-based approach for developing product-specific labeling instructions.
• To address the need for data-supported guidance on EFT medication administration, including pediatric and neonatal populations.

Main Methods:

• Review of regulatory agency recommendations for drug administration via EFT.
• Proposal of a risk-based testing strategy for oral drug products.
• Consideration of specific needs for neonatal and pediatric populations in testing protocols.

Main Results:

• Identification of risks associated with off-label oral drug administration via EFT.
• Framework for generating data to support or advise against EFT administration in product labeling.
• Emphasis on a risk-based approach to testing and instruction development.

Conclusions:

• Data-supported, product-specific instructions are essential for safe oral drug administration via EFT.
• A risk-based testing strategy can mitigate potential patient and caregiver risks.
• Testing protocols should encompass diverse patient populations, including neonates and pediatrics.